Medicine

All Articles

Prenatal direct exposure to famine influences long term health

.Nature Medicine, Published online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of inf...

A worldwide metric of immune system health and wellness

.Nature Medicine, Published online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A research stud...

Niacin, food intake and cardio results

.Nature Medication, Released online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, meals ...

Opportunities and difficulties for patient-reported outcome assessment in multimorbidity research study and also technique

.Contending passions.S.E.H. obtains financing coming from the National Institute of Wellness as well...

Hibernation science harnessed to handle excessive weight and also modify metabolism

.Nature Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy knowing th...

CAR- T and also mobile genetics therapies are actually as well expensive

.Mother Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of...

The that genomics system of work for fair implementation of individual genomics for international health

.The publication of the initial draft of the human genome sequence in 20011 was actually adhered to ...

A time-stratified, case\u00e2 $ \"crossover study of warmth direct exposure as well as perinatal mortality coming from 16 medical centers in sub-Saharan Africa

.One of 138,015 hospital-based individual births in 4 sub-Saharan African countries, our experts not...

Advancing international antibiotic study, growth and access #.\n\nMurray, C. J. L. et cetera. International trouble of bacterial antimicrobial protection in 2019: a step-by-step study. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Leaders. Towards certain dedications as well as activity in the action to antimicrobial protection. Global Leaders Group on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Globe Health Company. WHO posts listing of germs for which new antibiotics are urgently needed. Globe Health and wellness Company https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Planet Health Institution. That microbial top priority pathogens checklist, 2024: microbial microorganisms of hygienics value to lead research study, growth as well as tactics to stop as well as manage antimicrobial protection. Planet Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entry. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nPlanet Health And Wellness Organization. 2023 antibacterial representatives in clinical as well as preclinical advancement: an introduction and analysis. Globe Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Testimonial. May 19, 2016 \u00e2 $\" Addressing drug-resistant infections worldwide: ultimate document as well as referrals. Testimonial on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Consortium. DRIVE-AB outcomes: files and rundown. Drive abdominal muscle https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Appearing the wall structure: an ask for concerted activity on anti-biotics r &amp d. Boston Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Concise 51: Exactly how can the EU support maintainable innovation and also accessibility to efficient anti-biotics? policy alternatives for existing and brand new medicines. International Observatory on Health And Wellness Units and Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Anti-biotic make use of as well as resistance\u00e2 $\" confirming the evident. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Wellness Institution. 2021 Knowledgeable classification. That access, check out, book, distinction of anti-biotics for assessment and monitoring of utilization. Globe Wellness Organization https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Facility for Illness Deterrence and Command. Antimicrobial protection aim ats: just how can our experts reach them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). World Health Company. Shortage of advancement readied to undermine antibiotic performance as well as health gains. Globe Health Organization https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Just how antimicrobial resistance is actually connected to environment modification: an overview of two linked international obstacles. Int. J. Environ. Res. Public Health 20, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial contaminations: our team need immediate action and assets that focus on the weakest link. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health Institution. Immunization protection. World Wellness Association https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Disease prevention and also management in low-resource setups: the need for the nearby, the contextual and also the practical. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Difficulties of carrying out antimicrobial stewardship tools in low to center profit nations (LMICs). Affect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A brief past of the antibiotic era: sessions discovered as well as obstacles for the future. Front end. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Patient access in 14 high-income nations to brand new antibacterials permitted by the US Food and Drug Administration, European Medicines Organization, Japanese Pharmaceuticals as well as Medical Equipment Organization, or Health Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Wellness Organization. 2021 antibacterial agents in clinical and also preclinical development: an introduction and also evaluation. Globe Wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Anti-biotics: the business economics must support the science. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of innovation in antibacterial therapies. Medical Development Company https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Determining specialist usage of next-generation prescription antibiotics versus resistant Gram-negative infections in united state healthcare facilities: a retrospective accomplice research study. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of advancement in anti-bacterial rehabs. Biotechnology Innovation Company https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A systematic evaluation and also important analysis of motivation approaches for discovery and advancement of unfamiliar prescription antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nWellness Emergency Preparedness as well as Reaction Authority. Research and development of medical countermeasures. International Payment https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Compensation. Pre-draft proposition for an European alliance under Horizon Europe One Wellness Antimicrobial Resistance. International Commission https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Anti-biotic R &amp D Collaboration. Entasis Therapies and the Global Antibiotic Investigation &amp Progression Relationship to create a brand new procedure for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of industry- as well as non-industry-sponsored medical tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Wellness Organization. Amount of medical trial signs up through location, condition, period of advancement, age and also sex of trial attendees (1999\u00e2 $ \"2022). Globe Health and wellness Company https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Global Anti-biotic Experimentation Alliance. NeoSept1: a research to calculate the position of existing and brand-new anti-biotics combinations to address newborns who reside in medical center along with extreme blood poisoning. ISRCTN computer system registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Agency of Canada. Authorities of Canada makes significant financial investment to combat antimicrobial protection (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Global Antibiotic Trial And Error Relationship. Japan government funding assists GARDP\u00e2 $ s attempts to resist antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Structure. Novo Nordisk Groundwork partners with CARB-X to overcome drug-resistant contaminations. novo nordisk groundwork https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Health as well as Digital Manager Company. Study on delivering AMR health care countermeasures to the market place. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Predicting the appropriate size of worldwide pull rewards for antibacterial medicines. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entrance benefit for the growth of brand new prescription antibiotics. Harvard Kennedy School https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Field motivations as well as antibiotic protection: an intro to the antibiotic vulnerability reward. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An ambitious USG progressed devotion for subscription-based purchasing of novel antimicrobials as well as its expected roi. Facility for Global Advancement https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 assets in brand new prescription antibiotics would certainly pay \u00e2 $\" for everyone. Office of Health Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up fight against life-threatening diseases complying with productive world-first fly. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Congress. S. 1355 \u00e2 $\" PASTEUR Act of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Payment. Reform of the EU pharmaceutical legalisation. International Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Repayment designs to attack market failures for antimicrobials: strategies consumed France, Germany, Sweden, the UK, and also the USA. Health Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Alliance of Drug Manufacturers and Associations. Coming from resistance to strength: what could the potential antibiotic pipeline resemble? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Center &amp World Health And Wellness Company. Incentivising the advancement of brand new antibacterial procedures: 2023 report card due to the International AMR R&ampD Center as well as That. International AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK registration model for antibiotics thought about successful? Lancet Microorganism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimulations for the advancement and also going on the market of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et cetera. Global, regional, as well as national causes of little one death in 2000\u00e2 $ \"thirteen, with forecasts to update post-2015 priorities: an upgraded organized review. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial drug shortages from 2001 to 2013: implications for medical application. Clin. Corrupt. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French coverage device for medication scarcities: summary and styles coming from 2012 to 2018: an empirical retrospective research. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Examination of WHO antibiotic intake as well as accessibility targets in 76 nations, 2000\u00e2 $ \"15: an evaluation of pharmaceutical sales records. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Fighting the fakes: dealing with shoddy and falsified medicines. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it getting easier to secure prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nBlack Culture for Lab Medicine. Plan short as well as infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic usage for individual use in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research study. Trop. Med. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial consumption: analysis of core storehouses supplies to in-patient care health locations coming from 2017 to 2019 in Uganda. Trop. Medication. Corrupt. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Variants in the consumption of antimicrobial medicines in the International location, 2014\u00e2 $ \"2018: seekings and also ramifications coming from ESAC-Net and also WHO Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et al. Medicine deficiency: causes, influence, and also relief techniques. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Client access in 14 high-income countries to new antibacterials approved by the US Fda, European Medicines Company, Japanese Pharmaceuticals and also Medical Instruments Organization, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et al. Lost anti-biotics: a follow-up stock study in Europe, the U.S.A., Canada and Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness advancement for worldwide health and wellness. Br. Medication. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Business Partnership. The 2023 AMR Market Partnership progression questionnaire: production as well as the environment. amr Business Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Venture, D. &amp Gaule, P. Can medical items be established on a charitable basis? Looking into item development partnerships for neglected diseases. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et cetera. Reboot biomedical R&ampD in the international public passion. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Illness Management and Protection. Africa CDC initiates vibrant relocate to secure Africa\u00e2 $ s health and wellness future by producing a fifty billion buck health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Working out public-health copyright licensing contracts to improve access to wellness modern technologies: an insider\u00e2 $ s story. BMJ Glob. Wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New service versions for research and development along with cost criteria are actually needed to have to attain decent rates of medicines. Br. Medication. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Microorganisms Biopharmaceutical Accelerator. Stewardship as well as accessibility. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Prescription Antibiotic R &amp D Collaboration. Shinogi, GARDP and also CHAI announce site permit and collaboration agreements to deal with microbial diseases next to growing access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Business Partnership. Leaving the laboratory: tracking the decrease in AMR R&ampD professionals. amr Industry Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Health Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 contact us to activity on antimicrobial resistance. G7G20 Papers Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). Global Union on Aging &amp Infectious Diseases Community of America. 2024 AMR preparedness index progress report. Determining federal government action on AMR policy. International Coalition on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Meals as well as Agriculture Institution of the United Nations, United Nations Atmosphere Programme, Planet Health Institution &amp. World Company for Animal Health. Worldwide data source for tracking antimicrobial resistance (AMR): nation self-assessment study (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the wid...

Integrating liver endpoints in professional tests of cardio and also kidney illness

.Attributes Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspecti...